Abstract:Background: Rabdosia japonica has been historically used in China as a popular folk medicine for the treatment of cancer, hepatitis, and gastricism. Glaucocalyxin A (GLA), an ent-kaurene diterpene isolated from Rabdosia japonica, is one of the main active ingredients showing potent inhibitory effects against several types of tumor cells. To the best of our knowledge, studies regarding the structural modification and Structure- Activity Relations (SAR) of this compound have not yet been reported. Objective: The aim of this study was to discover more potent derivatives of GLA and investigate their SAR and cytotoxicity mechanisms. Methods: Novel 7-O- and 14-O-derivatives of GLA were synthesized by condensation of acids or acyl chloride. The anti-tumor activities of these derivatives against various human cancer cell lines were evaluated in vitro by MTT assays. Apoptosis assays of compound 17 (7,14-diacylation product) were performed on A549 and HL-60 cells by flow cytometry and TUNNEL. The acute toxicity of this compound was tested on mice, at the dose of 300mg per kg body weight. Results: Seventeen novel 7-O- and 14-O-derivatives of GLA (1-17) were synthesized. These compounds showed potent cytotoxicity against the tested cancer cell lines, and almost all of them were found to be more cytotoxic than GLA and oridonin. Of the synthesized derivatives, compound 17 presented the greatest cytotoxicity, with IC50 values of 0.26μM and 1.10μM in HL-60 and CCRF-CEM cells, respectively. Furthermore, this compound induced weak apoptosis of A549 cells but showed great potential in stimulating the apoptosis of HL- 60 cells. Acute toxicity assays indicated that compound 17 is relatively safer. Conclusion: The results reported herein indicate that the synthesized GLA derivatives exhibited greater cytotoxicity against leukemia cells than against other types of tumors. In particular, 7,14-diacylation product of GLA was found to be an effective anti-tumor agent. However, the cytotoxicity mechanism of this product in A549 cells is expected to be different than that in other tumor cell lines. Further research is needed to confirm this hypothesis.

Synthesis and antitumor activity of arginine–glucosamine conjugate

Antitumor Activities of D-glucosamine and Its Derivatives

Preliminary Studies on the Antitumor Activities of D-glucosamine and Its Derivatives

Synthesis and Cytotoxic Property of Annonaceous Acetogenin Glycoconjugates

Synthesis and In vitro anti-cancer Activity evaluation of Glucosamine Derivatives

Synthesis and biological evaluation of glaucocalyxin A derivatives as potential anticancer agents.

Synthesis and Study of Antitumor Activity of Artimisinin Glucoside

Synthesis, urease inhibitory and anticancer evaluation of glucosamine-sulfonylurea conjugates

Evaluation of Sulfated Α-Glucans from Poria Cocos Mycelia As Potential Antitumor Agent

Synthesis and Cytotoxicity Assessment of Novel 7-O- and 14-O-Derivatives of Glaucocalyxin A

Synthesis and Biological Evaluation of Novel Conjugates of Camptothecin and 5-Flurouracil As Cytotoxic Agents

Synthesis of Amino Acid-Modified Ursolic Acid Derivatives and Their Antitumor Activity Against Gastric Carcinoma

Synthesis and Anti-tumor Activities of Novel 18Β-Glycyrrhetinic Acid Derivatives Attaching Dithiocarbamate Units

Enzymatic Biosynthesis and Biological Evaluation of Novel 17-AAG Glucoside As Potential Anti-Cancer Agents.

Synthesis and in vitro antitumor activity of galactosamine–docetaxel conjugates

Synthesis, cytotoxicity and apoptosis of naphthalimide polyamine conjugates as antitumor agents

Synthesis and Antitumor Evaluation of Glycyrrhetinic Acid-Dithiocarbamate Hybrids.

Synthesis and Antitumor Activity of Nitric Oxide-Donating Glycyrrhetinic Acid Derivatives Coupled with Nitrate Moiety

Synthesis of glycyrrhetinic acid C3 and C30 derivatives and their antitumor activities in vitro

Synthesis and in Vitro Anti-tumor Evaluation of Novel Glycoconjugated SN38 Derivatives

Synthesis and anti-angiogenesis evaluation of mutual prodrugs of lenalidomide and glucosamines